Genetic and epigenetic alterations of BRG1 promote oral cancer development

  • Authors:
    • Esra Gunduz
    • Mehmet Gunduz
    • Mamoru Ouchida
    • Hitoshi Nagatsuka
    • Levent Beder
    • Hidetsugu Tsujigiwa
    • Kunihiro Fukushima
    • Kazunori Nishizaki
    • Kenji Shimizu
    • Noriyuki Nagai
  • View Affiliations

  • Published online on: January 1, 2005     https://doi.org/10.3892/ijo.26.1.201
  • Pages: 201-210
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Loss of heterozygosity (LOH) analysis is a sensitive method to detect deletions of specific chromosome regions which are considered to harbor of putative tumor suppressor gene (TSG)s. Previous allelotype analyses in various human cancers suggested the presence of at least one TSG in chromosome 19p13 region. Functional analysis of BRG1, a member of SWI/SNF complex proteins, located at 19p13.2, suggested it to be a candidate TSG in different types of human cancers. We examined LOH at 19p13 region in 39 oral cancers by using six microsatellite markers and found allelic deletion in 25 of 39 (64%) samples. A microsatellite marker near BRG1 locus showed the highest LOH in tumor samples. To clarify the role of BRG1 gene in oral carcinogenesis, we checked its mutation status in tumor samples. As mutation of the BRG1 gene was not detected in oral cancers, we examined the mRNA expression level. Quantitative RT-PCR analysis surprisingly demonstrated increased expression of BRG1 mRNA in 62% of primary tumors as compared with that of matched normal samples. Since functions of BRG1 and BRM, another member of SWI/SNF highly homologous to BRG1, may be interrelated, we also examined BRM mRNA expression in the same samples. In most samples, the expressions of BRG1 and BRM changed in the same direction consistent with reported data on human cancer cell lines. An important finding is that expression of an alternative in frame splicing form of BRG1 which includes exon 26 is selectively decreased or lost in most tumor samples. This unique 33 amino-acid sequence of BRG1 protein shows very high homology with heterogeneous nuclear ribonucleoprotein E and may affect the function and level of BRG1 through modifications on post-transcriptional control. All these findings suggest that the genetic and epigenetic alterations of BRG1 may have a role in oral cancer development.

Related Articles

Journal Cover

January 2005
Volume 26 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Gunduz, E., Gunduz, M., Ouchida, M., Nagatsuka, H., Beder, L., Tsujigiwa, H. ... Nagai, N. (2005). Genetic and epigenetic alterations of BRG1 promote oral cancer development. International Journal of Oncology, 26, 201-210. https://doi.org/10.3892/ijo.26.1.201
MLA
Gunduz, E., Gunduz, M., Ouchida, M., Nagatsuka, H., Beder, L., Tsujigiwa, H., Fukushima, K., Nishizaki, K., Shimizu, K., Nagai, N."Genetic and epigenetic alterations of BRG1 promote oral cancer development". International Journal of Oncology 26.1 (2005): 201-210.
Chicago
Gunduz, E., Gunduz, M., Ouchida, M., Nagatsuka, H., Beder, L., Tsujigiwa, H., Fukushima, K., Nishizaki, K., Shimizu, K., Nagai, N."Genetic and epigenetic alterations of BRG1 promote oral cancer development". International Journal of Oncology 26, no. 1 (2005): 201-210. https://doi.org/10.3892/ijo.26.1.201